{"id":{"repo_id":"usf","oai_identifier":"oai:digitalcommons.usf.edu:etd-10842"},"canonical_url":"https://search.ndltd.org/etd/usf/oai:digitalcommons.usf.edu:etd-10842","repository":{"repo_id":"usf","name":"University of South Florida","base_url":"https://digitalcommons.usf.edu/do/oai/"},"display":{"title":"Design, Synthesis and Testing of Bioactive Peptidomimetics","abstract":"Proteins are complex macromolecules that are responsible for almost all biochemical processes and play vital roles in signaling pathways, metabolic pathways, and all other cellular functions. Proteins accomplish this by interacting with other proteins and macromolecules like DNA and RNA, for instance, as transcription factors. As such, we can find protein interactions behind every cellular action or inaction, and it is easy to see how protein interactions are crucial in understanding disease processes. Advance in proteomics has particularly provided a wealth of insights into molecular mechanisms of disease processes of cancers and other rare diseases, which has helped identify key therapeutic protein targets for intervention. In this work, we describe the design, synthesis, and testing of peptidomimetic protein-protein interaction inhibitors. We employed our Sulfonyl--AA-peptide based helical mimetics to develop rationally designed inhibitors of VEGF and HIF-1[U+F061], two cancer targets responsible for angiogenesis and hypoxia respectively, hallmarks of cancer cells. Our mimics demonstrated effective inhibition of the targeted protein-protein interactions. We also describe the synthesis of a -AA-peptide based macrocyclic peptidomimetic library to identify hits against VEGF and LPS. We also describe hits optimizations to develop promising lead compounds effective against drug resistant Gram-negative bacteria.","abstract_html":"Proteins are complex macromolecules that are responsible for almost all biochemical processes and play vital roles in signaling pathways, metabolic pathways, and all other cellular functions. Proteins accomplish this by interacting with other proteins and macromolecules like DNA and RNA, for instance, as transcription factors. As such, we can find protein interactions behind every cellular action or inaction, and it is easy to see how protein interactions are crucial in understanding disease processes. Advance in proteomics has particularly provided a wealth of insights into molecular mechanisms of disease processes of cancers and other rare diseases, which has helped identify key therapeutic protein targets for intervention. In this work, we describe the design, synthesis, and testing of peptidomimetic protein-protein interaction inhibitors. We employed our Sulfonyl--AA-peptide based helical mimetics to develop rationally designed inhibitors of VEGF and HIF-1[U+F061], two cancer targets responsible for angiogenesis and hypoxia respectively, hallmarks of cancer cells. Our mimics demonstrated effective inhibition of the targeted protein-protein interactions. We also describe the synthesis of a -AA-peptide based macrocyclic peptidomimetic library to identify hits against VEGF and LPS. We also describe hits optimizations to develop promising lead compounds effective against drug resistant Gram-negative bacteria.","abstract_has_math":false,"creators":["Abdulkadir, Sami"],"institution":"University of South Florida","degree_name":"Doctor of Philosophy (Ph.D.)","degree_level":"Dissertation","degree_discipline":"Chemistry","degree_department":null,"school":null,"contributors":["Jianfeng Cai, Ph.D.","James Leahy, Ph.D.","Wayne Guida, Ph.D.","Cheng Feng, Ph.D."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2021,"date_issued":"2021-06-29T07:00:00Z","date_published":"2021-06-29T07:00:00Z","updated_at":"2026-11-19T08:48:12Z","subjects":["Helix Mimetic","HIF-1 Alpha Inhibitor","LPS Inhibitor","Macrocyclic Peptide Library","Protein-Protein interaction inhibitor","VEGF Inhibitor","Chemistry"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://digitalcommons.usf.edu/etd/9645","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://digitalcommons.usf.edu/etd/9645","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://digitalcommons.usf.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adigitalcommons.usf.edu%3Aetd-10842","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Jianfeng Cai, Ph.D.","James Leahy, Ph.D.","Wayne Guida, Ph.D.","Cheng Feng, Ph.D."]},{"key":"dc:creator","label":"Author","values":["Abdulkadir, Sami"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2021-06-29T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Chemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation","Ph.D."]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy (Ph.D.)"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of South Florida"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Helix Mimetic","HIF-1 Alpha Inhibitor","LPS Inhibitor","Macrocyclic Peptide Library","Protein-Protein interaction inhibitor","VEGF Inhibitor","Chemistry"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.usf.edu/etd/9645"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Proteins are complex macromolecules that are responsible for almost all biochemical processes and play vital roles in signaling pathways, metabolic pathways, and all other cellular functions. Proteins accomplish this by interacting with other proteins and macromolecules like DNA and RNA, for instance, as transcription factors. As such, we can find protein interactions behind every cellular action or inaction, and it is easy to see how protein interactions are crucial in understanding disease processes. Advance in proteomics has particularly provided a wealth of insights into molecular mechanisms of disease processes of cancers and other rare diseases, which has helped identify key therapeutic protein targets for intervention. In this work, we describe the design, synthesis, and testing of peptidomimetic protein-protein interaction inhibitors. We employed our Sulfonyl--AA-peptide based helical mimetics to develop rationally designed inhibitors of VEGF and HIF-1[U+F061], two cancer targets responsible for angiogenesis and hypoxia respectively, hallmarks of cancer cells. Our mimics demonstrated effective inhibition of the targeted protein-protein interactions. We also describe the synthesis of a -AA-peptide based macrocyclic peptidomimetic library to identify hits against VEGF and LPS. We also describe hits optimizations to develop promising lead compounds effective against drug resistant Gram-negative bacteria."]},{"key":"dc:title","label":"Title","values":["Design, Synthesis and Testing of Bioactive Peptidomimetics"]}]}],"canonical_facts":{"dc:contributor":["Jianfeng Cai, Ph.D.","James Leahy, Ph.D.","Wayne Guida, Ph.D.","Cheng Feng, Ph.D."],"dc:creator":["Abdulkadir, Sami"],"dc:date":["2021-06-29T07:00:00Z"],"dc:description":["Proteins are complex macromolecules that are responsible for almost all biochemical processes and play vital roles in signaling pathways, metabolic pathways, and all other cellular functions. Proteins accomplish this by interacting with other proteins and macromolecules like DNA and RNA, for instance, as transcription factors. As such, we can find protein interactions behind every cellular action or inaction, and it is easy to see how protein interactions are crucial in understanding disease processes. Advance in proteomics has particularly provided a wealth of insights into molecular mechanisms of disease processes of cancers and other rare diseases, which has helped identify key therapeutic protein targets for intervention. In this work, we describe the design, synthesis, and testing of peptidomimetic protein-protein interaction inhibitors. We employed our Sulfonyl--AA-peptide based helical mimetics to develop rationally designed inhibitors of VEGF and HIF-1[U+F061], two cancer targets responsible for angiogenesis and hypoxia respectively, hallmarks of cancer cells. Our mimics demonstrated effective inhibition of the targeted protein-protein interactions. We also describe the synthesis of a -AA-peptide based macrocyclic peptidomimetic library to identify hits against VEGF and LPS. We also describe hits optimizations to develop promising lead compounds effective against drug resistant Gram-negative bacteria."],"dc:identifier":["https://digitalcommons.usf.edu/etd/9645"],"dc:subject":["Helix Mimetic","HIF-1 Alpha Inhibitor","LPS Inhibitor","Macrocyclic Peptide Library","Protein-Protein interaction inhibitor","VEGF Inhibitor","Chemistry"],"dc:title":["Design, Synthesis and Testing of Bioactive Peptidomimetics"],"thesis:degree_discipline":["Chemistry"],"thesis:degree_level":["Dissertation","Ph.D."],"thesis:degree_name":["Doctor of Philosophy (Ph.D.)"],"thesis:institution_name":["University of South Florida"]},"updated_at":"2026-11-19T08:48:12Z"}